Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Reply to V. Pitini et al.

Mayer EL, Lin NU.

J Clin Oncol. 2013 Jun 10;31(17):2225-6. No abstract available.

PMID:
23901420
2.

Reply to V. Pitini et al.

Romond EH, Rastogi P, Jeong JH.

J Clin Oncol. 2013 Jun 10;31(17):2225. No abstract available.

PMID:
23901419
3.

Questionable validity of cardiac risk score on the basis of the NSABP B-31 model.

Pitini V, Arrigo C, Mondello P, Altavilla G.

J Clin Oncol. 2013 Jun 10;31(17):2224. doi: 10.1200/JCO.2012.47.2696. Epub 2013 May 6. No abstract available.

PMID:
23650420
4.

Long term follow-up of national surgical adjuvant breast and bowel project trial B-31: how well can we predict cardiac toxicity with trastuzumab?

Mayer EL, Lin NU.

J Clin Oncol. 2012 Nov 1;30(31):3769-72. doi: 10.1200/JCO.2012.44.9611. Epub 2012 Sep 17. No abstract available.

PMID:
22987088
5.

The end of an era: shall we move forward?

Dang C.

J Clin Oncol. 2011 Oct 10;29(29):3849-51. doi: 10.1200/JCO.2011.36.7417. Epub 2011 Sep 12. No abstract available.

PMID:
21911728
6.

Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.

Brower V.

J Natl Cancer Inst. 2013 Jun 19;105(12):835-6. doi: 10.1093/jnci/djt161. Epub 2013 Jun 2. No abstract available.

PMID:
23733910
7.

Liposomal anthracyclines for breast cancer: overview.

O'Shaughnessy J.

Oncologist. 2003;8 Suppl 2:1-2. Review. No abstract available.

8.

Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

Ewer MS, Lenihan DJ.

J Clin Oncol. 2008 Mar 10;26(8):1201-3. doi: 10.1200/JCO.2007.14.8742. Epub 2008 Jan 28. No abstract available.

PMID:
18227525
9.

Paclitaxel and doxorubicin in metastatic breast cancer.

Sharma S.

J Clin Oncol. 1996 Apr;14(4):1403. No abstract available.

PMID:
8648400
10.

[Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide].

Franzen D, Pöhler E, Hilger HH.

Med Klin (Munich). 1990 Mar;85 Suppl 1:133-6, 170. German. No abstract available.

PMID:
2160577
11.

New developments in adjuvant therapy for breast cancer.

Sledge GW Jr.

Clin Adv Hematol Oncol. 2005 Sep;3(9):688-90. No abstract available.

PMID:
16224442
12.

Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer.

Morris PG, Iyengar NM, Patil S, Chen C, Abbruzzi A, Lehman R, Steingart R, Oeffinger KC, Lin N, Moy B, Come SE, Winer EP, Norton L, Hudis CA, Dang CT.

Cancer. 2013 Nov 15;119(22):3943-51. doi: 10.1002/cncr.28284. Epub 2013 Aug 26.

13.

Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer.

Basser RL, Abraham R, To LB, Fox RM, Green MD.

Ann Oncol. 1999 Jan;10(1):53-8.

PMID:
10076722
14.

Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.

Ventura GJ.

J Clin Oncol. 2005 Apr 20;23(12):2873; author reply 2873-4. No abstract available.

PMID:
15838014
15.

Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.

Tan-Chiu E, Yothers G, Romond E, Geyer CE Jr, Ewer M, Keefe D, Shannon RP, Swain SM, Brown A, Fehrenbacher L, Vogel VG, Seay TE, Rastogi P, Mamounas EP, Wolmark N, Bryant J.

J Clin Oncol. 2005 Nov 1;23(31):7811-9.

PMID:
16258083
16.
17.

The heart of the matter.

Portera CC, Swain SM.

J Clin Oncol. 2007 Sep 1;25(25):3794-6. Epub 2007 Jul 30. No abstract available.

PMID:
17664459
18.

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

Eiermann W, Pienkowski T, Crown J, Sadeghi S, Martin M, Chan A, Saleh M, Sehdev S, Provencher L, Semiglazov V, Press M, Sauter G, Lindsay MA, Riva A, Buyse M, Drevot P, Taupin H, Mackey JR.

J Clin Oncol. 2011 Oct 10;29(29):3877-84. doi: 10.1200/JCO.2010.28.5437. Epub 2011 Sep 12.

PMID:
21911726
19.

In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).

Munshi A, Jalali R, Budrukar A.

Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):632; author reply 632-3. No abstract available.

PMID:
16690446
20.

Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.

Coccaro M, Gallucci G.

J Clin Oncol. 2008 Jul 1;26(19):3288; author reply 3289. doi: 10.1200/JCO.2008.17.3203. No abstract available.

PMID:
18591567

Supplemental Content

Support Center